FDA Investigator Mary C Acton
Mary C Acton has inspections in 1 countries as of 12 Sep 2023. Mary C Acton has collaborated with a combined 2089 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
32
Last Inspection Date:
12 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abha R Bommireddi,
Adam S Freeman,
Alec M O'neal,
Alex G Kalugin,
Alexandra M Cossi,
Alison A Nicoli,
Andersoneric,
Angel K Sandhu,
Anna J Vickrey,
Avery J Dennis,
Baker,
Barbara J Arrais,
Belinda E Clifton,
Breena L D'ambrogi,
Bruce D Broidy,
Camacho,
Capri R Woolridge,
Carl Lee,
Carr,
Chloe Anne K Le,
Chloe Anne Leong,
Christine M Parmentier,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Courtney R Warren,
Craig K Hopkins,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Darla R Bracy,
David A Laplante,
David A Lum,
Davina M Martinez,
Edna J Hidalgo,
Elaine S Chow,
Elodie Xtong Lin,
Elva M Ibarra,
Emmanuel O Kerry,
Erica R Pomeroy,
Estefania Fernandez,
Frank P Bianco,
Gary L Hartman,
Gina M Hall,
Gulshan R Anand,
Helen J Hamaoka,
Ismael Garibay,
James C Yee,
Janice Wai,
Jazmine M Welcher,
Jeanne A Young,
Jennifer Crumb,
Jennifer L Johnson,
Jennifer S King,
Jessica B Darneille,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Liu,
Juan A Morales,
Juliane Kjung Lau,
Karen D Phung,
Karen J Bak,
Karen M Willis,
Karla J Gibler,
Kelvin X Sanders,
Kenneth S Boehnen,
Keren Arkin,
Kevin P Foley,
Larkin R Buckalew,
LCDR Jennifer H Rhyu,
Lee,
Leongc,
Ligia M Sanders,
Lija V Fellows,
Linda S Shook,
Lisa H Nakagawa,
Lucila B Nwatu,
Luis A Solorzano,
Lynn L Wong,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Maridali De Leon Torres,
Mark I Nakano,
Mary C Wall,
Matthew A Walburger,
Matthew K Wong,
Mcgrewp,
Megan E Kulas,
Mei Chiung J Huang,
Melody M Ragasa Leong,
Michelle L Orner,
Nicole Yuen,
Nympha V Florendo,
Paula E Davis Debella,
Peter E Baker,
Phung,
Quynh H Strandberg,
Randall P Zielinski,
Randy L Elsberry,
Rebecca E Sulpacio,
Roberta K Smith,
Roger D Gawne,
Samuel J Barone, III,
Sandra S Saniga,
Sara M Richardson,
Sean P Desbrow,
Sergio Chavez (NMI),
Siobhan A Gallagher,
State Agency,
Stephanie L Kelly,
Steven C Himebaugh,
Steven J Branch,
Steven M Galvez,
Stuart Kim,
Thomas N Adjabeng,
Thomas W Gordon,
Todd M Bozicevich,
Vebina K Sethi,
Victoria L Morgan,
Wayne L Jefferson,
Wen Jun Peng,
Willemsj,
William J Foust,
William J Weis,
Yen Tso Kuo
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more